Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (72)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Pulmonary edema has more than one mechanism
- Aspiration exposes alveoli to damaging material
- ARDS and DAD are not interchangeable labels
- The damaged barrier permits alveolar exudation
- The exudative phase changes gross lung appearance
- Collagen deposition can remodel alveolar walls
- Host factors may modify risk
- Primary references and source boundaries
Slide index & full transcript (72 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Edema caused by microvascular (alveolar) injury
Noncardiogenic pulmonary edema, acute lung injury, and diffuse alveolar damage
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Distinguish permeability-related pulmonary edema from hydrostatic edema.
Explain endothelial and epithelial injury mechanisms in ALI/ARDS.
Correlate hyaline membranes, organizing injury, and clinical respiratory failure.
Interpret representative clinical scenarios using pathology mechanisms.
Slide 3 · Pulmonary edema has more than one mechanism
Hemodynamic edema
Primarily increased hydrostatic pressure
Common association: Left-sided heart failure
Alveolar fluid is mainly transudative
Alveolar wall–injury edema
Primary barrier injury and increased permeability
Endothelial and/or alveolar epithelial damage
Inflammatory, protein-rich exudate
Slide 4 · The intact alveolar–capillary barrier
ALVEOLAR AIR SPACE
INTERSTITIUM
PULMONARY CAPILLARY
Schematic · Thin alveolar epithelium, interstitium, and capillary endothelium
Slide 5 · Two cellular layers regulate alveolar dryness
Alveolar epithelium
Type I cells constitute thin gas-exchange lining
Type II pneumocytes maintain surfactant
Epithelial continuity supports edema clearance
Pulmonary capillary endothelium
Forms vascular interface of alveolar septum
Activation changes adhesion and permeability
Injury permits movement of inflammatory exudate
Slide 6 · Noncardiogenic edema begins with septal injury
Alveolar septal injury
Vascular permeability increases
Inflammatory exudate leaks
Interstitial → alveolar edema
Protein leakage follows a loss of barrier integrity rather than pressure overload alone.
Slide 7 · Primary endothelial injury: Vascular entry point
Endothelial activation or damage may initiate permeability edema.
Activated vessels become adhesive and proinflammatory.
Leakage starts in the interstitium and may reach the alveolar air spaces.
Epithelial injury often amplifies the pulmonary damage.
Slide 8 · Primary epithelial injury: Alveolar entry point
Pneumocyte damage
Alveolar macrophage sensing
TNF release
Secondary endothelial activation
Initial epithelial damage can trigger a secondary vascular inflammatory response.
Slide 9 · Severity changes the compartment containing fluid
Barrier insult
Interstitial fluid accumulation
More severe permeability loss
Intraalveolar exudate
Alveolar flooding represents more advanced injury than isolated interstitial edema.
Slide 10 · What the edema fluid signifies
Hemodynamic mechanism
Raised hydrostatic pressure
Transudate: Pale intraalveolar material
Often associated with vascular congestion
Inflammatory permeability mechanism
Endothelial or epithelial damage
Exudate: Protein-rich edema fluid
Fibrin and epithelial debris may form hyaline membranes
Slide 11 · Direct and indirect causes converge on the lung
Direct injury to the lung
Indirect / systemic injury
Infection
Bacterial or diffuse pneumonia
Aspiration
Gastric contents or near-drowning
Inhalation
Oxygen toxicity; Smoke; Irritant gases
Tissue injury
Contusion, trauma, radiation
Systemic
Sepsis; Burns; Pancreatitis; Trauma
Transfusion
Transfusion-associated lung injury
Drugs / chemicals
Listed medications and toxins
Other contexts
DIC, uremia, cardiopulmonary bypass
Slide 12 · Pulmonary infection is an important direct insult
Diffuse pulmonary infection is one of the principal associations with ARDS.
Textbook examples include viral, Mycoplasma, pneumocystis, and miliary tuberculosis.
Bacterial pneumonia can directly injure the alveolar wall.
Local epithelial injury can provoke macrophage-dependent inflammation.
Slide 13 · Aspiration exposes alveoli to damaging material
Gastric aspiration
Direct alveolar injury
Inflammation and barrier leak
ALI/ARDS
The initiating insult occurs directly at the alveolar surface.
Slide 14 · Inhaled agents can injure the alveolar septum
High oxygen concentrations may produce oxygen toxicity.
Smoke and irritant gases are recognized inhalational triggers.
These are lung-directed injuries rather than isolated elevation of venous pressure.
Clinical context identifies the injurious exposure.
Slide 15 · Physical and environmental lung injury
Pulmonary contusion follows direct thoracic injury.
Near-drowning introduces liquid-associated lung injury.
Radiation and severe burns are among listed injury contexts.
Major mechanical trauma, including head injury, is associated with ARDS.
Slide 16 · Systemic inflammation can initiate lung injury
Severe systemic insult
Circulating mediators
Pulmonary endothelial activation
Permeability edema
A distant source of inflammation can damage the alveolar–capillary interface.
Slide 17 · Sepsis is a major associated trigger
Circulating inflammatory signals can activate pulmonary capillary endothelium directly.
Endothelial changes recruit neutrophils and favor barrier dysfunction.
Sepsis can coexist with other injuries, intensifying pulmonary damage.
Sepsis among the prominent ARDS-associated conditions.
Slide 18 · Transfusion and hematologic associations
Transfusion-associated lung injury appears in the list of ARDS associations.
Disseminated intravascular coagulation is another listed hematologic context.
Systemic and hematologic insults can converge on pulmonary endothelial injury.
Association alone does not specify a unique histologic pattern.
Slide 19 · Drugs and chemicals are heterogeneous triggers
Examples
Heroin or methadone overdose
Aspirin or barbiturate overdose
Paraquat and other chemicals
Pathology implication
A chemical or medication exposure may precede ALI.
The common consequence is alveolar wall injury.
Drug history helps identify the initiating condition.
Slide 20 · Multiple concurrent insults may coexist
Concurrent systemic insults
Sepsis and severe tissue injury
Shock and extensive trauma
More than one trigger may be present
Coexisting pulmonary stresses
Oxygen therapy may coexist
Diffuse pulmonary infection may coexist
Combined insults can worsen lung damage
Slide 21 · ALI is a clinicopathologic lung-injury syndrome
An abrupt onset of hypoxemia.
Bilateral pulmonary edema occurs without cardiac failure as the explanation.
Increased pulmonary vascular permeability accompanies epithelial cell death.
The resulting histologic injury pattern is diffuse alveolar damage.
Slide 22 · ARDS represents severe acute lung injury
Acute barrier injury
Permeability-related edema
Progressive oxygenation failure
ARDS
Severe permeability edema is coupled to worsening gas-exchange failure.
Slide 23 · ARDS and DAD are not interchangeable labels
ARDS
Clinical syndrome
Severe acute respiratory insufficiency
Often occurs with identifiable systemic or pulmonary trigger
Diffuse alveolar damage (DAD)
Histologic pattern of injury
Edema, epithelial damage, hyaline membranes
May evolve into organizing/fibroproliferative injury
Slide 24 · Acute interstitial pneumonia: No identified trigger
A minority of acute presentations occur without known initiating conditions.
The source calls this rapidly progressive presentation acute interstitial pneumonia.
Distinction from triggered ALI/ARDS is clinical, chiefly whether a precipitant is found.
Similar forms of acute lung injury may occur in either setting.
Slide 25 · The early injury has multiple cellular targets
Alveolar compartment
Type I and type II pneumocytes
Resident alveolar macrophages
Injury may begin at epithelial surfaces
Vascular and recruited cells
Pulmonary endothelial cells
Circulating and migrating neutrophils
Cell interactions amplify barrier dysfunction
Slide 26 · Macrophages translate epithelial injury into signals
Epithelial injury
Alveolar macrophage sensing
TNF release
Endothelial activation
Resident macrophages connect tissue damage with endothelial inflammation.
Slide 27 · Systemic mediators provide a second initiating route
Sepsis or severe tissue injury
Circulating inflammatory mediators
Pulmonary endothelium
Activation and damage
Endothelial activation can occur even without a primary airway insult.
Slide 28 · Endothelial activation changes the vessel surface
Functional change
Increased adhesion molecules
Increased procoagulant proteins
Chemokine expression
Pathologic effect
Facilitates neutrophil attachment
Promotes a procoagulant endothelial phenotype
Supports leukocyte recruitment into lung
Slide 29 · Neutrophils cross the activated capillary wall
Adhere to endothelium
Pass into interstitium
Enter alveolar spaces
Release injurious mediators
Slide 30 · Activated neutrophils amplify damage
Proteases can damage cellular and extracellular components.
Reactive oxygen species contribute to inflammatory tissue injury.
Cytokines reinforce recruitment and activation of inflammatory cells.
This amplifies microvascular and alveolar epithelial damage.
Slide 31 · NETs: A possible additional source of damage
Neutrophil extracellular traps (NETs) may be released in ALI/ARDS.
Experimental evidence supporting a direct damaging contribution.
NETs supplement, rather than replace, protease and oxidant-mediated injury.
The degree of contribution is not quantified in the supplied source.
Slide 32 · Inflammation creates a self-amplifying loop
Endothelial activation
Neutrophil recruitment
Proteases · ROS · cytokines
Worsening tissue damage
Amplified inflammation feeds back to injure the barrier
Further endothelial damage perpetuates permeability and leukocyte activation.
Slide 33 · The damaged barrier permits alveolar exudation
ALVEOLAR AIR SPACE
Protein-rich edema
Epithelial loss
INTERSTITIUM
PULMONARY CAPILLARY
Increased permeability
Schematic · Endothelial–epithelial injury allows exudation into air spaces
Slide 34 · Type II cell injury compromises surfactant
Type II pneumocyte damage
Surfactant abnormalities
Reduced alveolar function
Worse gas exchange
Surfactant disruption adds mechanical dysfunction to barrier leakage.
Slide 35 · Hyaline membranes form from edema and cell debris
Exudative fluid component
Protein-rich alveolar edema fluid
Fibrin-rich deposits along injured walls
Contributes the proteinaceous matrix
Necrotic cellular component
Damaged pneumocyte remnants
Cellular debris admixed with fibrin
Combined material forms hyaline membranes
Slide 36 · Hyaline membranes identify exudative DAD
The membranes line injured alveolar walls.
They are composed of fibrin-rich fluid and epithelial necrotic debris.
Them as waxy on histologic sections.
They are characteristic of DAD, but are not a separate ARDS diagnostic test.
Slide 37 · Edema removal is impaired by epithelial injury
Pneumocyte necrosis
Impaired fluid-resorption capacity
Persistence of alveolar fluid
Sustained gas-exchange impairment
The same injury that causes flooding also slows fluid resolution.
Slide 38 · ALI/ARDS is patchy at the functional level
Poorly aerated regions
Lower regional compliance
Alveolar edema and epithelial damage
Persisting pulmonary perfusion
Relatively preserved regions
Near-normal compliance may remain
Ventilation can be relatively maintained
Substantial within-lung heterogeneity
Slide 39 · Perfused but underventilated units worsen hypoxemia
Relatively preserved unit
Poorly aerated injured unit
Ventilation preserved
Perfusion continues
Ventilation ↓
Perfusion continues
Perfusion of poorly ventilated alveoli worsens arterial hypoxemia.
Slide 40 · Why supplemental oxygen may be insufficient
Edema / low aeration
Ventilation–perfusion mismatch
Marked hypoxemia
Oxygen therapy may not normalize it
Poorly aerated but perfused alveoli contribute to severe oxygenation defects.
Slide 41 · Reduced lung compliance increases ventilatory demand
Loss of functional surfactant contributes to stiff lungs.
Some involved units become poorly aerated and low-compliance.
Severe respiratory failure may require intubation.
High ventilatory pressures may be necessary to maintain gas exchange.
Slide 42 · The exudative phase changes gross lung appearance
Lungs become heavy and firm because of accumulated fluid and tissue injury.
They are characteristically red and boggy.
Capillary congestion and interstitial edema occur together.
In more advanced involvement, alveolar spaces contain exudate.
Slide 43 · Exudative DAD: Core microscopic changes
Congestion accompanies interstitial and intraalveolar edema.
Inflammation and fibrin deposition are present.
Necrosis of alveolar epithelial cells contributes to tissue damage.
Hyaline membranes line injured alveoli.
Slide 44 · Schematic recognition of hyaline membranes
Alveolar air space
Hyaline membrane: Fibrin-rich exudate + epithelial remnants
Schematic only — not H&E photomicrograph
Slide 45 · Membrane composition explains its appearance
Derived from edema fluid
Protein-rich exudate
Fibrin accumulation
Inspissated material along alveolar surfaces
Derived from damaged epithelium
Necrotic epithelial fragments
Cellular debris
Admixture with fibrinous exudate
Slide 46 · Radiology mirrors uneven airspace injury
Acute disease can show patchy ground-glass opacities.
Consolidation may coexist with ground-glass regions.
Diffuse bilateral infiltrates develop with clinical respiratory failure.
Imaging findings complement but do not replace pathologic context.
Slide 47 · Organizing injury follows the exudative phase
Exudative alveolar damage
Type II cell proliferation
Granulation tissue formation
Organizing lung injury
Inflammatory injury is followed by regeneration and fibroblastic organization.
Slide 48 · Type II pneumocytes participate in repair
Proliferation of surviving type II pneumocytes is characteristic of organizing DAD.
Residual type II cells can replace lost type I pneumocytes.
Re-epithelialization helps restore the alveolar lining.
Repair can progress over an extended period.
Slide 49 · Granulation tissue appears in organizing DAD
The organizing phase involves granulation tissue in alveolar walls.
Granulation tissue can also develop within alveolar spaces.
Fibroblastic activity follows prior injury and inflammation.
The extent of organization influences subsequent structural recovery.
Slide 50 · DAD evolves through recognizable responses
Exudative injury
Capillary leak; Edema; Epithelial death; Hyaline membranes
Organizing response
Type II pneumocyte proliferation and granulation tissue
Divergent outcome
Alveolar repair and recovery or collagen deposition with fibrosis
Slide 51 · Fibrogenic mediators follow inflammatory clearance
Macrophage activity
TGF-β and PDGF
Fibroblast growth
Collagen deposition
Tissue repair can become a fibrogenic response after severe injury.
Slide 52 · Collagen deposition can remodel alveolar walls
Fibroblasts deposit collagen in previously injured alveolar septa.
The wall becomes fibrotic when repair remains fibroproliferative.
Fibrosis reduces normal architectural flexibility.
Persistent interstitial fibrosis can contribute to chronic pulmonary disease.
Slide 53 · Inflammatory clearance is part of resolution
Trigger diminishes
Macrophage clearance
Debris removed
Repair pathways continue
Resolution requires the original inflammatory trigger to subside.
Slide 54 · Epithelial repair reconstitutes alveolar lining
Surviving type II cells
Type II proliferation
Replacement of type I cells
Lining restored
Surviving type II cells supply regenerative potential for the epithelial surface.
Slide 55 · Endothelial integrity can also recover
Proliferation of uninjured capillary endothelial cells supports restoration.
Repair must occur on the vascular side as well as in the alveolar lining.
Edema resolution becomes more feasible as epithelial function recovers.
The balance between restoration and fibrosis helps determine outcome.
Slide 56 · The recovery pathway is not uniform
Recovery / resolution
Inflammatory stimuli subside
Debris clearance and cell regeneration
Most survivors recover pulmonary function
Persistent structural disease
Fibroproliferation and collagen deposition
Residual interstitial fibrosis
Potential chronic pulmonary limitation
Slide 57 · Clinical onset is often abrupt and severe
Profound dyspnea and rapid breathing are prominent early findings.
Progressive hypoxemia may produce cyanosis.
Respiratory failure evolves with increasing bilateral lung opacities.
The syndrome is commonly observed in critically ill patients.
Slide 58 · Respiratory failure reflects several coupled lesions
Alveolar edema
Surfactant dysfunction
Regional low compliance
Gas-exchange failure
Barrier failure, surfactant loss, and regional low compliance act together.
Slide 59 · Morphology, physiology, and imaging align
Structural lesion
Interstitial / alveolar edema
Hyaline membranes and cell necrosis
Uneven airspace involvement
Functional consequence
Impaired diffusion and ventilation
Reduced functional surfactant
V/Q mismatch and refractory hypoxemia
Slide 60 · Outcomes depend on injury and systemic illness
Fatal outcomes may be associated with sepsis and multiorgan failure.
Severe lung injury itself also contributes to mortality.
Most survivors recover pulmonary function.
A minority develop interstitial fibrosis with chronic pulmonary disease.
Slide 61 · Historical ICU data: Interpret within its period
A 2016 study conducted in ICUs across 50 countries.
ARDS accounted for 10.4% in that reported ICU study.
Reported mortality was 35%, 40%, and 46% for mild, moderate, and severe ARDS.
These are historical study estimates—not present-day universal probabilities.
Slide 62 · Host factors may modify risk
Epidemiologic studies cited link smoking with worse ARDS prognosis.
Alcohol use disorder is also associated with greater susceptibility and poorer outcomes.
Genetic variants associated with risk include loci connected to inflammation or coagulation.
The supplied text does not define a clinical genetic risk test.
Slide 63 · Injury edema and hemodynamic edema differ
Feature
Hemodynamic pulmonary edema
Microvascular injury edema
Principal mechanism
Hydrostatic pressure increase
Endothelial / epithelial injury
Common context
Left-sided cardiac failure
Sepsis, aspiration, severe lung injury
Fluid character
Transudate
Protein-rich inflammatory exudate
Characteristic histology
Congestion; Heart-failure cells possible
DAD; Hyaline membranes may develop
Slide 64 · Clinical case: Septic patient with bilateral edema
A critically ill patient with sepsis develops abrupt breathlessness, hypoxemia, and bilateral pulmonary opacities. No cardiac failure is identified.
Interpretation prompts
What makes permeability edema likely?
Which pulmonary cell surface is activated early?
Name the characteristic histologic injury pattern.
Slide 65 · Case interpretation: Sepsis-associated lung injury
Systemic mediators may directly activate pulmonary microvascular endothelium.
Neutrophil recruitment and epithelial injury produce permeability exudation.
The associated histologic pattern is diffuse alveolar damage.
Hyaline membranes may occur in the exudative phase.
Slide 66 · Clinical case: Hydrostatic or permeability edema?
One patient with left-sided cardiac failure develops congested, fluid-filled lungs. Another has acute respiratory failure after gastric aspiration.
Interpretation prompts
Which is more consistent with increased hydrostatic pressure?
Which is more consistent with direct alveolar wall injury?
How would the expected edema character differ?
Slide 67 · Case interpretation: Identify the mechanism
Left-sided heart failure commonly raises hydrostatic pressure and produces transudative edema.
Gastric aspiration directly injures lung tissue and may cause inflammatory edema.
Microvascular injury can cause DAD with hyaline membranes.
Clinical context and tissue changes distinguish the mechanisms.
Slide 68 · Clinical case: Organizing lung injury
Following severe acute lung injury, surviving tissue shows type II pneumocyte proliferation, granulation tissue, and emerging collagen deposition.
Interpretation prompts
Which phase of diffuse alveolar damage is represented?
What cells rebuild the alveolar epithelial surface?
What could determine persistent physiologic impairment?
Slide 69 · Case interpretation: Organizing DAD
The proliferative or organizing phase follows exudative alveolar injury.
Residual type II pneumocytes regenerate lining cells, including type I cells.
Fibrogenic mediators stimulate fibroblast growth and collagen deposition.
Extensive fibrosis can contribute to chronic lung dysfunction.
Slide 70 · Integrated pathogenesis of injury-related edema
Direct or systemic insult
Endothelial / epithelial injury
Inflammation and protein-rich edema
DAD ± fibrosis
Histologic DAD and the clinical ARDS phenotype are related but distinct.
Slide 71 · Five mechanistic points to retain
The defining mechanism is alveolar wall injury with increased vascular permeability.
Local epithelial damage or systemic inflammation can activate endothelium.
Neutrophil mediators sustain an injury–inflammation feedback loop.
Protein-rich edema plus epithelial debris produces hyaline membranes.
Recovery requires epithelial/endothelial repair; Some cases evolve toward fibrosis.
Slide 72 · Primary references and source boundaries
Robbins, Cotran & Kumar
Pathologic Basis of Disease, 11th edition (2026), Chapter 15: The Lung
Pulmonary edema, acute lung injury, ARDS, and diffuse alveolar damage; printed pages 614–617.
Relevant source tables: 15.1 and 15.2; referenced textbook figures: 15.3 and 15.4.